Beyond Air, Inc. (XAIR)
0.41
-0.04 (8.89%)
Upcoming Events
Latest Headlines
Form 8-K Beyond Air, Inc. For: May 28
June 1, 2026 4:33 PM - SEC Filing
Beyond Air gets Nasdaq extension to regain bid price compliance by July 31
June 1, 2026 8:03 AM - StreetInsider
Beyond Air Receives Nasdaq Hearing Panel Decision Granting Continued Listing
June 1, 2026 8:01 AM - Globe NewsWire
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: Alyeska Investment Group, L.P.
May 15, 2026 4:56 PM - SEC Filing
Form SCHEDULE 13G/A Beyond Air, Inc. Filed by: BALYASNY ASSET MANAGEMENT L.P.
May 15, 2026 6:36 AM - SEC Filing
Form DEF 14A Beyond Air, Inc. For: May 05
May 5, 2026 4:31 PM - SEC Filing
Form PRE 14A Beyond Air, Inc. For: Apr 24
April 24, 2026 4:31 PM - SEC Filing
Beyond Cancer presents Phase 1 UNO trial survival data at AACR 2026
April 20, 2026 8:02 AM - StreetInsider
Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026
April 20, 2026 8:00 AM - Globe NewsWire
Form 8-K Beyond Air, Inc. For: Apr 13
April 15, 2026 5:00 PM - SEC Filing
Beyond Air to Participate in the D. Boral Capital Global Conference 2026
April 15, 2026 8:00 AM - Globe NewsWire
Form 8-K Beyond Air, Inc. For: Apr 07
April 10, 2026 4:31 PM - SEC Filing
Form 8-K Beyond Air, Inc. For: Mar 26
April 1, 2026 4:30 PM - SEC Filing
Beyond Air secures group purchasing agreement for LungFit PH system
April 1, 2026 9:01 AM - StreetInsider
Beyond Air Expands Commercial Access for LungFit® PH Through a Purchasing Agreement with a Top 3 National Group Purchasing Organization (GPO)
April 1, 2026 9:00 AM - Globe NewsWire
BTIG reiterates Neutral rating on Beyond Air (XAIR) amid CEO change
March 26, 2026 5:46 PM - StreetInsider
Beyond Air names Robert Goodman as new CEO following Steve Lisi resignation
March 26, 2026 4:05 PM - StreetInsider
Beyond Air, Inc. Announces Resignation of Steve Lisi, CEO, and Appointment of Robert Goodman, Chief Commercial Officer, as CEO
March 26, 2026 4:05 PM - Globe NewsWire
Beyond Cancer reports early clinical activity in Phase 1 cancer trial
March 17, 2026 4:35 PM - StreetInsider
Beyond Cancer Reports Early Clinical Activity and Favorable Safety Profile with Interim Data from Phase 1 UNO Trial
March 17, 2026 4:35 PM - Globe NewsWire
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026 8:35 AM - StreetInsider
Beyond Air to Participate in the 38th Annual Roth Conference in March
March 11, 2026 7:00 AM - Globe NewsWire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026 10:22 AM - StreetInsider
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026 10:21 AM - Globe NewsWire
Beyond Air terminates NeuroNOS sale deal with XTL Biopharmaceuticals
March 10, 2026 7:30 AM - StreetInsider
Beyond Air® Announces Termination of Agreement to Sell Its NeuroNOS Subsidiary to XTL Biopharmaceuticals Ltd.
March 10, 2026 7:30 AM - Globe NewsWire
Full Article List
